INS and Alzheimer disease: Emerging evidence suggests that glucose hypometabolism, insulin resistance, and impaired insulin-like growth factor (IGF) signaling are linked to AD progression, leading to the characterization of AD as “type 3 diabetes” (Rivera et al., 2005; Steen et al., 2005).